Alzheimer’s Studies and Trials
Reset Filter
Actively Enrolling
50-85, Clinical Trial, Memory Impairement
Synaptic Therapy Alzheimer’s Research Trial
This study is investigating whether CT1812, a novel and promising therapeutic candidate can halt or slow the process of Alzheimer’s disease. The START Study is a nationwide clinical trial and…
Actively Enrolling
40+, Clinical Trial, Memory Impairement
Life’s End Benefits of Cannabidiol and Tetrahydrocannabinol (LiBBY)
Approximately fifty percent of people diagnosed with Alzheimer’s disease or other types of dementia will receive hospice care at the end of their life. Of these, over seventy percent will…
Active – Fully Enrolled
50-90, Memory Impairement, Normal Memory, Observational - In Person
Alzheimer’s Disease Neuroimaging Initiative (ADNI)
The Alzheimer’s Disease Neuroimaging Initiative (ADNI), a landmark study that began in 2004, is a public-private research partnership tasked with identifying biomarkers to detect Alzheimer’s disease (AD). The study has…